Batu Biologics, Inc. — Form D/A
Batu Biologics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2017-05-10. The offering totals $1.2M, of which $508K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-05-10
- Form: D/A
- Accession: 0001612629-17-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $1.2M
- Amount sold: $508K
- Remaining: $692K
- Minimum investment: $10K
- Investors: 9
- Date of first sale: 2016-01-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-256471
Issuer
- Name: Batu Biologics, Inc.
- CIK: 0001612629
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2013
- Address: 9255 TOWNE CENTRE DR., SUITE 450, SAN DIEGO, CA, 92121
- Phone: 2133593179
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Vladimir Nikolaos Bogin | Director | San Diego, CA |
| John Nikolaos Chiplin | Director | La Jolla, CA |
| Thomas E Ichim | Director | Oceanside, CA |
| Alan Nikolaos Lewis | Director | San Diego, CA |
| Hong Nikolaos Ma | Director | San Diego, CA |
| John Nikolaos Peck | Director | Rancho Santa Fe, CA |
| Samuel C Wagner | Director | San Diego, CA |
| Gerry Nikolaos Berg | Executive Officer | San Diego, CA |
| Dimitrios Nikolaos Theofilopoulos | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More